| Product Code: ETC9563451 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Premenstrual Dysphoric Disorder Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Premenstrual Dysphoric Disorder Market - Industry Life Cycle |
3.4 Sweden Premenstrual Dysphoric Disorder Market - Porter's Five Forces |
3.5 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.8 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Premenstrual Dysphoric Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and understanding of premenstrual dysphoric disorder (PMDD) among healthcare professionals and the general population in Sweden |
4.2.2 Growing acceptance and adoption of pharmacological and non-pharmacological treatment options for PMDD in the Swedish healthcare system |
4.2.3 Rising prevalence of PMDD in Sweden due to lifestyle changes, stress factors, and hormonal imbalances |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of specialized healthcare services and resources for PMDD diagnosis and treatment in Sweden |
4.3.2 Stigma and misconceptions surrounding mental health conditions, including PMDD, leading to underreporting and undertreatment |
4.3.3 Regulatory challenges and restrictions impacting the development and approval of new PMDD treatment options in the Swedish market |
5 Sweden Premenstrual Dysphoric Disorder Market Trends |
6 Sweden Premenstrual Dysphoric Disorder Market, By Types |
6.1 Sweden Premenstrual Dysphoric Disorder Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.4 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Nonsteroidal Anti-inflammatory Drugs (NSAIDs), 2021- 2031F |
6.1.5 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.6 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Exercise, 2021- 2031F |
6.1.8 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Diet, 2021- 2031F |
6.2 Sweden Premenstrual Dysphoric Disorder Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Premenstrual Dysphoric Disorder Market, By Symptoms |
6.3.1 Overview and Analysis |
6.3.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Depression, 2021- 2031F |
6.3.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intense Anger, 2021- 2031F |
6.3.4 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Mood Swings, 2021- 2031F |
6.3.5 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Irritability, 2021- 2031F |
6.3.6 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Premenstrual Dysphoric Disorder Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Premenstrual Dysphoric Disorder Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.5.4 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sweden Premenstrual Dysphoric Disorder Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.4 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Sweden Premenstrual Dysphoric Disorder Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Sweden Premenstrual Dysphoric Disorder Market Revenues & Volume, By , 2021- 2031F |
7 Sweden Premenstrual Dysphoric Disorder Market Import-Export Trade Statistics |
7.1 Sweden Premenstrual Dysphoric Disorder Market Export to Major Countries |
7.2 Sweden Premenstrual Dysphoric Disorder Market Imports from Major Countries |
8 Sweden Premenstrual Dysphoric Disorder Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for PMDD patients in Sweden |
8.2 Percentage of healthcare providers trained in PMDD recognition and management |
8.3 Patient-reported outcomes related to quality of life improvements and symptom relief following PMDD treatment |
8.4 Number of clinical trials and research studies focused on PMDD treatment conducted in Sweden |
8.5 Adoption rate of multidisciplinary approaches (e.g., therapy, medication, lifestyle modifications) in PMDD management in Swedish healthcare facilities |
9 Sweden Premenstrual Dysphoric Disorder Market - Opportunity Assessment |
9.1 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.4 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Sweden Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Premenstrual Dysphoric Disorder Market - Competitive Landscape |
10.1 Sweden Premenstrual Dysphoric Disorder Market Revenue Share, By Companies, 2024 |
10.2 Sweden Premenstrual Dysphoric Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here